Ethics and Compliance Hotline
Cardiff Oncology's Board of Directors approved the Anonymous Ethics and Compliance Hotline on December 9, 2015 which is effective as of January 1, 2016.
Cardiff Oncology, Inc. promotes a trustworthy and honest work environment and reinforces the vision of these ethics within the organization. Cardiff Oncology will not tolerate any wrongdoing or impropriety and takes allegations of fraud, waste and abuse very seriously. Cardiff Oncology is committed to achieving the highest possible standards of ethics and behavior in its corporate governance and workplace.
It is Cardiff Oncology policy to comply with all applicable laws and to protect employees against unlawful discrimination or retaliation by their employer as a result of their lawfully reporting information regarding, or their participation in, investigations involving violations by Cardiff Oncology or its agents of federal or state law.
In order to facilitate the reporting of complaints, Cardiff Oncology has established this whistleblower hotline through Lighthouse Services, Inc. If you have a matter that you wish to bring to our attention, please select one of the following methods to report your complaints or concerns.
- Toll-Free Telephone:
English speaking USA and Canada: 844-280-0005
Spanish speaking USA and Canada: 800-216-1288
Spanish speaking Mexico: 01-800-681-5340
French speaking Canada: 855-725-0002
- Website: www.lighthouse-services.com/cardiffoncology
- E-mail: firstname.lastname@example.org (must include company name with report)
- Fax: (215) 689-3885 (must include company name with report)
Lighthouse toll free number and other methods of reporting are available 24 hours a day, 7 days a week. Complaints should be as detailed and complete as possible and include references to any supporting documentation in order to allow effective and efficient investigation thereof. Cardiff Oncology’s Audit Committee will oversee investigation and treatment of employee concerns collected. Unless you choose to provide it, personally identifiable information remains confidential.